Filter Results:
(459)
Show Results For
- All HBS Web
(459)
- News (140)
- Research (224)
- Multimedia (8)
- Faculty Publications (138)
Show Results For
- All HBS Web
(459)
- News (140)
- Research (224)
- Multimedia (8)
- Faculty Publications (138)
- June 2021
- Article
From Predictions to Prescriptions: A Data-driven Response to COVID-19
By: Dimitris Bertsimas, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg and Cynthia Zeng
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at... View Details
Keywords: COVID-19; Health Pandemics; AI and Machine Learning; Forecasting and Prediction; Analytics and Data Science
Bertsimas, Dimitris, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg, and Cynthia Zeng. "From Predictions to Prescriptions: A Data-driven Response to COVID-19." Health Care Management Science 24, no. 2 (June 2021): 253–272.
- April 2011
- Supplement
Brazil: Leading the BRICs? (PPT)
By: Arthur A. Daemmrich
Keywords: Brazil
Daemmrich, Arthur A. "Brazil: Leading the BRICs? (PPT)." Harvard Business School PowerPoint Supplement 711-106, April 2011.
- 1995
- Chapter
Pharmaceutical Companies and Health Care Reform
By: Arthur A. Daemmrich
- 1999
- Chapter
Biotechnology, Competitiveness and the Regulatory State
By: Arthur A. Daemmrich
- September 2004
- Article
Rethinking Mergers and Acquisitions: How to Involve R&D in Company Growth
By: Arthur A. Daemmrich
- 13 Mar 2007
- First Look
First Look: March 13, 2007
site for paper: http://www.bepress.com/cas/vol1/iss3/art3/ Identity Negotiation Processes Amidst Diversity: Understanding the Influence of Social Identity and Status Differences Authors:Jeffrey T. Polzer and Heather M. Caruso Publication:In Diversity at Work, edited... View Details
Keywords: Martha Lagace
- October 2012
- Teaching Note
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships
By: Arthur A. Daemmrich
- December 2010
- Supplement
Denmark: Globalization and the Welfare State (PPT)
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Denmark: Globalization and the Welfare State (PPT)." Harvard Business School PowerPoint Supplement 711-057, December 2010.
- December 2010 (Revised April 2012)
- Background Note
Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round
By: Arthur A. Daemmrich
This note analyzes disputes over intellectual property enforcement and agricultural trade barriers at the center of the Doha Round of World Trade Organization (WTO) negotiations. Fundamental principles of intellectual property rights and agricultural subsidies are... View Details
Keywords: Agribusiness; Trade; Globalization; Governance; International Relations; Intellectual Property; Agreements and Arrangements; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Daemmrich, Arthur A. "Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round." Harvard Business School Background Note 711-043, December 2010. (Revised April 2012.)
- January 2009 (Revised July 2009)
- Case
Targanta Therapeutics: Hitting a Moving Target
By: Arthur A. Daemmrich
This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details
Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry
Daemmrich, Arthur A. "Targanta Therapeutics: Hitting a Moving Target." Harvard Business School Case 709-002, January 2009. (Revised July 2009.)
- 2004
- Book
R&D Meets M&A: Proceedings of the 2003 Conference on Innovation and Creativity in Chemical R&D
By: Arthur A. Daemmrich
Keywords: Research and Development; Mergers and Acquisitions; Conferences; Innovation and Invention; Creativity; Science
Daemmrich, Arthur A., ed. R&D Meets M&A: Proceedings of the 2003 Conference on Innovation and Creativity in Chemical R&D. Chemical Heritage Press, 2004.
- January 2000
- Article
The Tragedy of the Commoners: Biotechnology and its Publics
By: Arthur A. Daemmrich
Keywords: Biotechnology Industry
Daemmrich, Arthur A. "The Tragedy of the Commoners: Biotechnology and its Publics." Nature Biotechnology 18, no. 1 (January 2000): 2–4.
- December 2000
- Article
Risk versus Risk: Tragic Choices in Drug Regulation in the United States and Germany
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Risk versus Risk: Tragic Choices in Drug Regulation in the United States and Germany." Science as Culture 9, no. 4 (December 2000): 505–534.
- fall 2002
- Article
Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial." Chemical Heritage, no. 20 (fall 2002): 12–13, 28–33.
- Article
Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate." Pharmacy in History 45, no. 1 (2003): 3–17.
- 07 Aug 2012
- First Look
First Look: August 7
case:http://hbr.org/search/812158-PDF-ENG GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships Arthur A. Daemmrich and Ian McKown CornellHarvard Business School Case 712-049 Three years into a... View Details
Keywords: Sean Silverthorne
- December 2020 (Revised December 2022)
- Case
The Dance of Dharma: On the Difficulty of Being Good
By: Arthur I. Segel and Tyler M. Richard
When deciding how to be good and act well, we often seek outside help. Many of our oldest and most frequently consulted sources of ethical guidance are our religious traditions. Just as one might consult a thoughtful friend, countless people seek direction from their... View Details
Segel, Arthur I., and Tyler M. Richard. "The Dance of Dharma: On the Difficulty of Being Good." Harvard Business School Case 821-058, December 2020. (Revised December 2022.)
- June 2011 (Revised October 2012)
- Case
Patagonia Sur: For-Profit Land Conservation in Chile
By: Arthur I Segel, Nicolas Ibanez and Jay Verjee
Warren Adams founded Patagonia Sur in 2007 as one of the world's first for-profit land conservation businesses. His goal was to purchase over 100,000 acres of land in southern Chile and to run a variety of sustainable businesses to generate annual returns for... View Details
Keywords: Business Model; Environmental Sustainability; Profit; Investment; For-Profit Firms; Entrepreneurship; Investment Return; Revenue; Risk and Uncertainty; Capital; SWOT Analysis; Real Estate Industry; Chile
Segel, Arthur I., Nicolas Ibanez, and Jay Verjee. "Patagonia Sur: For-Profit Land Conservation in Chile." Harvard Business School Case 211-103, June 2011. (Revised October 2012.)
- 13 Jan 2009
- First Look
First Look: January 13, 2009
nonprofits and corporations can create value for society more effectively by applying strategy principles to philanthropy. Part V explores the link between strategy and leadership. Risk Frameworks and Biomonitoring: Distributed Regulation... View Details
Keywords: Martha Lagace